Reactive oxygen species (ROS) have been implicated in vascular smooth muscle cell (VSMC) apoptosis, a hallmark of advanced atherosclerotic lesions. 1 Apoptosis is an essential component of normal development as well as of most developmental abnormalities and human diseases (1) . Vascular smooth muscle cell (VSMC) apoptosis occurs after vessel injury, in remodeling, and in advanced atherosclerotic lesions (2) (3) (4) . A significant increase in VSMC death rate was observed in unstable versus stable angina plaques, suggesting the involvement of VSMC apoptosis in plaque rupture (5) . Indeed, direct stimulation of VSMC apoptosis induces destabilization and rupture of atherosclerotic plaques (6, 7) . Plaque rupture often leads to thrombosis with clinical manifestations of myocardial infarction or stroke. Atherosclerotic lesions are a highly prooxidant environment and contain high LAR Deficiency Enhances H 2 O 2 -induced VSMC Apoptosis 2 levels of reactive oxygen species (ROS), which can induce VSMC apoptosis (8) (9) (10) (11) .
In addition to atherosclerosis, ROS have been implicated in hypertension and other vascular diseases, and intracellular signaling cascades stimulated by ROS play an important role in the pathogenesis of these diseases. ROS-induced stimulation of protein phosphorylation pathways modulates transcription factor activities and gene expression, which results in a variety of responses such as cell growth, differentiation or apoptosis (12, 13) . The particular response observed will depend on the cell type, and the concentration and duration of ROS production.
Hydrogen peroxide, the most stable form of ROS, inhibits protein tyrosine phosphatases (PTP) in vitro and reversibly in intact cells (14) (15) (16) (17) . PTP contain a catalytically essential cysteine residue in their signature active site motif, HCXXGXXR(S/T) (where X is any amino acid), with an extremely low pKa (18). The low pKa promotes the function of the cysteine as a nucleophile in catalysis, but renders it a target of oxidation with concomitant inhibition of PTP activity (14, 19) . Recently, Groen et al. (20) reported that PTP undergo differential oxidation at physiological pH and H 2 O 2 concentrations, which indicates that cellular responses are fine-tuned to various oxidative stimuli. ROS generation is the proximal event in cell surface receptor activation by growth factors and cytokines. PTP control protein tyrosine phosphorylation, which is a key regulatory mechanism of many intracellular signaling pathways. Therefore, oxidation and inhibition of PTP by ROS may be an initial and critical step for ROS and growth factor-induced signaling in cells (14, (21) (22) (23) . However, very little is known about the role of individual PTP in regulating ROS-induced signaling.
The mammalian leukocyte common antigen-related receptor (LAR) protein tyrosine phosphatase family includes LAR, PTPδ and PTPσ (24) . LAR is expressed on the cell surface as a complex of two noncovalently associated subunits of 150 and 80 kDa, which are derived by the action of an endogenous protease on a preprotein (25, 26) . The 150-kDa extracellular subunit comprises the N-terminus of the protein, contains three tandem immunoglobulin-like domains and eight fibronectin-III like domains, and is modified by N-linked glycosylation. The 85-kDa Cterminal subunit contains a short ectodomain, a transmembrane domain and two tandem phosphatase domainsthe membrane-proximal D1 domain has phosphatase activity and the distal D2 domain is catalytically inactive, but may regulate substrate specificity (27) .
LAR has wide tissue distribution including the lung, heart, brain, liver and kidney, and it is expressed in various cell lineages including epithelial cells, smooth muscle cells, and cardiomyocytes (25, 28) .
Cell culture and animal model studies have shown that this PTP acts as a negative regulator of insulin signaling (29) (30) (31) .
Recently, we reported that LAR regulates insulin-like growth factor-1 receptor signaling in VSMC, and dysregulation of this PTP affects vascular pathophysiology (32) . In the present study, we examined the effect of LAR on H 2 O 2 -induced signal transduction pathways and apoptosis using aortic VSMC derived from LAR knockout mice. Our results indicate that LAR regulates the viability of VSMC under oxidative stress conditions. Absence of LAR enhances H 2 O 2 -induced VSMC apoptosis, by allowing hyperactivation of the Fyn/JAK2/STAT3 and Fyn/p38 MAP kinase pathways. were generated by gene trap method (33, 34) . LAR -/-littermates were derived via heterozygous crosses and were backcrossed at least 8 times into the DBA background. Genotyping was done using RT-PCR as described by Yeo et al (35) .
EXPERIMENTAL PROCEDURES

MaterialsAG490
Cell CultureAortic VSMC were isolated from 4-month old male LAR +/+ and LAR -/-mice as previously described by our group (36) . Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS), as described previously (37) . Human aortic VSMC (Cambrex Corporation) were cultured in smooth muscle cell basal medium containing 5% FBS, 100 ng/ml insulin, 200 ng/ml human fibroblast growth factor, 100 ng/ml human epidermal growth factor, 50 µg/ml gentamicin and 50 ng/ml amphotericin. All experiments were conducted using VSMC between passages 4 and 11 that were growth-arrested by incubation in DMEM containing 0.1% FBS for 72 h.
Immunoprecipitation and Western AnalysisCells were lysed either in radioimmune precipitation buffer (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.05 mM sodium fluoride, 1 mM EDTA, 1% Igepal CA-630, 0.05% sodium deoxycholate and 0.1% sodium dodecyl sulfate) or Triton lysis buffer (20 mM Tris-HCl, pH 7.4, 137 mM NaCl, 2 mM EDTA, 10% glycerol and 1% Tritox X-100) containing protease inhibitors. Immunoprecipitation, and Western analysis were performed as described previously (36) . Puromycin-resistant clones (selected with 2 µg/ml puromycin for 10 days) were expanded prior to their use in experiments. The effectiveness of Fyn shRNA was confirmed by Western blotting of cell lysates with anti-Fyn antibodies.
Measurement of LAR
Fyn Kinase AssayAfter appropriate treatments, cells were washed with cold PBS, and lysed on ice for 15 min in lysis buffer containing 20 mM HEPES, pH 7.4, 2 mM EGTA, 1 mM dithiothreitol, 50 mM β-glycerophosphate, 1% Triton X-100, 10 units/ml aprotinin, 2 µM leupeptin, 1 mM Na 3 VO 4 , and 400 µM phenylmethylsulfonyl fluoride. Cell lysates containing 500 µg of protein were immunoprecipitated with antiFyn antibody for 2 h at 4 o C and then incubated with 40 µl of 50% (w/v) protein A-Sepharose beads for an additional 1 h. The beads were washed three times with lysis buffer and resuspended in 30 µl kinase buffer (20 mM Tris, pH 7.5, 10 mM MnCl 2 , 10 mM MgCl 2 ) containing 2.5 µg denatured human nonneuronal enolase, 5 µM ATP and 5 µCi of [γ-32 P]ATP and incubated at 37ºC for 15 min. The reactions were stopped by adding 20 µl of 4x Laemmli sample buffer. The samples were heated at 95°C for 5 min and analyzed by SDS-gel electrophoresis on 10% acrylamide gels. The dried gel was exposed to x-ray film and developed. Levels of phosphorylatedenolase were quantified by densitometry.
Statistical AnalysisAll numerical data are expressed as mean ± SEM. Data were analyzed with one-way and two-way analysis of variance (ANOVA) and in case of one-way ANOVA, post-hoc analysis was performed using the Newman-Keuls test. Statistical significance was accepted at p < 0.05 We further confirmed that absence of LAR enhances H 2 O 2 -induced VSMC apoptosis by measuring changes in mitochondrial membrane potential using MitoCapture reagent (Fig. 2B ). VSMC were treated with or without 1 mM H 2 O 2 for 3 h prior to MitoCapture staining. In untreated wild-type and LAR knockout VSMC, the fluorescence of MitoCapture was red indicating mitochondrial accumulation and healthy cells. Following H 2 O 2 treatment, increase in green fluorescence was evident in both wild-type and LAR knockout cells, indicating apoptosis. Consistent with other markers of apoptosis, the ratio of green-tored + green fluorescence was significantly higher in LAR knockout VSMC than in wildtype VSMC (p < 0.001) (Fig. 2C ).
RESULTS
LAR activity is inhibited
Finally, we tested whether increase in apoptosis after H 2 O 2 treatment was associated with decrease in VSMC viability using crystal violet staining ( Fig. 2A, lower panel) (46) . To determine whether LAR deficiency has differential effects on activation of Fyn and other Src family kinases, Lck and c-Src, we analyzed tyrosine phosphorylation of these kinases in cellular extracts of wild-type and LAR knockout VSMC treated with 1 mM H 2 O 2 . Tyrosine phosphorylation of Fyn and cSrc was assessed by immunoprecipitation of cell lysates with their respective antibodies and then probing the immunoprecipitates with anti-phosphotyrosine (PY20) antibody, whereas Lck tyrosine phosphorylation was assessed by immunoblotting the cell lysates with anti-phosphospecific Lck antibody. A significant increase in Fyn tyrosine phosphorylation was observed with time and cell type (p < 0.0001, 2-way ANOVA) in response to H 2 O 2 treatment (Fig. 3A and B) . Sustained increase in Lck and c-Src phosphorylation was observed with time in both cell types when treated with H 2 O 2 (p < 0.0001 for each kinase, 2-way ANOVA) (Fig.  3C-F (Fig. 5A and B) . To determine whether enhanced activation of JAK2 in LAR knockout VSMC treated with H 2 O 2 leads to tyrosine phosphorylation of signal transducer and activator of transcription 3 (STAT3), a JAK2 substrate, we measured STAT3 tyrosine phosphorylation in wild-type and LAR knockout VSMC treated with H 2 O 2 (Fig. 5C ). H 2 O 2 treatment caused significant increase in STAT3 tyrosine phosphorylation with time and cell-type (p < 0.0001, 2-way ANOVA) in VSMC (Fig. 5D) .
Fyn tyrosine kinase is upstream of p38 mitogen-activated protein (MAP) kinase in the signal transduction pathways of several cells, including vascular cells (51, 52) . Because the activation of p38 MAP kinase has been implicated in apoptosis of VSMC (53,54), we examined the activation of this kinase in wildtype and LAR knockout VSMC treated with H 2 O 2 (Fig. 5E) . Phosphorylation of p38 MAP kinase was significantly higher in LAR knockout VSMC than in wild-type cells 5 (p < 0.01), 10 (p < 0.001) and 20 min (p < 0.05) after H 2 O 2 treatment (Fig. 5F) .
LAR binds to and dephosphorylates activated Fyn─Because Fyn kinase tyrosine phosphorylation was increased in LAR knockout VSMC and LAR was shown to bind Fyn in other cell types (46), we investigated whether the regulatory function of LAR on Fyn is mediated by a direct physical interaction between the two proteins in VSMC treated with H 2 O 2 . LAR knockout VSMC, infected with either human AdLAR or Adβ-gal, were treated with or without H 2 O 2 for 10 min. Immunoprecipitation of these cell lysates with anti-Fyn antibody followed by Western analysis with anti-LAR C-terminal antibody revealed enhanced association of LAR with activated Fyn kinase in VSMC following treatment with H 2 O 2 (Fig. 6A) . The association of LAR with activated Fyn was corroborated using lysates from LAR knockout VSMC infected with human AdLAR and treated with H 2 O 2 . Immunoprecipitation of cell lysates with anti-Fyn antibody followed by Western analysis with anti-LAR C-terminal antibody and reciprocal immunoprecipitation with anti-LAR C-terminal antibody and Western analysis with Fyn antibody confirmed enhanced association of LAR with activated Fyn (Fig. 6B) .
Next we examined whether LAR dephosphorylates Fyn in vitro. LAR knockout VSMC were treated with H 2 O 2 for 10 min and activated Fyn in the lysates was immunoprecipitated with anti-Fyn antibody and incubated with purified recombinant LAR (New England Biolabs) or vehicle. As shown in Fig. 6C (upper (Fig. 7, E and F) . PP2 pretreatment also significantly inhibited H 2 O 2 -induced phosphorylation of p38 MAP kinase in both wild-type and LAR -/-VSMC (p < 0.001 versus H 2 O 2 treatment for 10 min for both the cell types) (Fig. 7, G and H (Fig. 8, B and C) (Fig. 8,  F and G) (Fig. 9, A and B Fig. 9, E and F) . In contrast, p38 MAP kinase phosphorylation induced by H 2 O 2 was unaffected by AG490 in both the cell types (Fig. 9, G and H (Fig. 10B) (Fig. 10C) (Fig. 4) .
The critical role of Fyn activation in redox-sensitive mechanisms is evident from the impaired ROS-induced cellular signaling pathways in various Fyn knockout cells (43, 45) . Further, caspase activation and DNA fragmentation induced by various proapoptotic stimuli are significantly reduced in embryonic fibroblasts and thymocytes from Fyn knockout mice (60) , which strengthens the idea that Fyn activation is a critical event in stress-induced apoptosis. These observations are in agreement with our data that silencing of Fyn expression by shRNA significantly attenuated H 2 O 2 -induced downstream signaling pathways (Fig. 8) and apoptosis in both wild-type and LAR knockout VSMC (Fig.  10) .
Regulation of Src-family kinase activity occurs through phosphorylation on two tyrosine residues (48). Autophosphorylation of tyrosine in the activation loop (Tyr419 in Fyn) increases kinase activity, whereas phosphorylation of tyrosine residue in the C-terminus (Tyr530 in Fyn) inhibits activity through an intramolecular SH2 (Src homology 2)-phosphotyrosine interaction. It has been suggested that dephosphorylation of tyrosine in the C-terminal domain precedes the autophosphorylation of tyrosine in the activation loop for full kinase activity (61) . However, Sanguinetti et al. (49) demonstrated that concomitant with autophosphorylation, oxidative stress also increased phosphorylation of the inhibitory site of Fyn, which indicates that activation of Fyn is rapidly followed by inactivation. Activation of Fyn could also be regulated by LAR as this activated PTP is associated with Fyn and dephosphorylates the phosphotyrosine residues in both the kinase domain and Cterminus (46) . Consistent with these observations, our results demonstrate enhanced association of LAR with activated Fyn in H 2 O 2 -treated VSMC (Fig. 5, A and B) and increased autophosphorylation and sustained activation of Fyn in LAR knockout VSMC treated with H 2 O 2 . This occurred in spite of increased phosphorylation of Tyr530 in Fyn. Furthermore, absence of LAR impaired mitochondrial membrane potential in VSMC treated with H 2 O 2 and enhanced caspase-3/7 activity and apoptosis (Fig. 2) .
Our data indicate increased activation of JAK2 and STAT3 in wild-type VSMC and significantly enhanced activation of these proteins in LAR knockout VSMC compared to wild-type cells in response to H 2 O 2 treatment. In addition, inhibition of Fyn activity with PP2 pretreatment abrogated H 2 O 2 -induced JAK2 and STAT3 stimulation in both wild-type and LAR knockout mice. These data are in consonance with the observations that H 2 O 2 -stimulated JAK2 activity was completely inhibited in Fyn knockout cells (43) , and that Fyn directly interacts with activated JAK2 (62) .
The JAK2-specific inhibitor, AG490, not only abrogated H 2 O 2 -induced stimulation of STAT3 (Fig. 8, C and D) , but also significantly attenuated H 2 O 2 -induced apoptosis in both wild-type and LAR knockout cells (Fig. 9B) . These results are in agreement with the observation of Sandberg and Sayeski (50) that activation of JAK2 is essential for H 2 O 2 -induced apoptosis of VSMC. They have shown that JAK2 activation leads to induction of proapoptotic Bax expression, impaired mitochondrial membrane integrity and activation of caspases. Further, AG490 treatment markedly reduced ischemia-induced infarct size and cardiomyocyte apoptosis (63) . Although STAT3 activation is usually associated with cell proliferation, strong and prolonged activation of STAT3 induces apoptosis (64, 65) , which further supports our conclusions that hyper activation of the Fyn/JAK2/STAT3 pathway in the absence of LAR induces VSMC apoptosis.
Our data indicate that H 2 O 2 -induced p38 MAP kinase activity, which was increased in wild-type VSMC, was further enhanced in the absence of LAR. PP2 pretreatment abrogated H 2 O 2 -induced p38 MAP kinase activity, whereas AG490 had no such inhibitory effect. These data confirm that Fyn is upstream of p38 MAP kinase activation (51, 52) and that Fyn/JAK2/STAT3 and Fyn/p38 MAP kinase are two distinct signaling pathways involved in oxidative stress-induced VSMC apoptosis. It is well documented that p38 MAP kinase plays a critical role in apoptosis induced by several agonists (54, 66, 67) . Phosphorylation of Bcl-2 by activated p38 MAP kinase in mitochondrial compartment leads to cytochrome c release and caspase activation and these processes are absent in p38 MAP kinase-deficient cells (68) .
In conclusion, our results demonstrate that LAR is a redox-sensor and negative regulator of H 2 O 2 -induced apoptosis in VSMC. Moreover, our report elucidates Fyn/JAK2/STAT3 and Fyn/p38 MAP kinase pathways as intracellular mediators of H 2 O 2 -induced VSMC apoptosis. Our data also suggest tissue/cell-specific effect of LAR as its activation/expression was correlated with increased apoptosis in other tissues (69-71). PTP inhibitor development is an active area of research for the treatment of obesity and diabetes. However, our data cautions on the use of such a strategy because apoptosis, induced by exacerbated oxidative stress prevalent under such pathophysiological conditions, may profoundly affect many vascular diseases.
FIGURE LEGENDS
Fig. 1. H 2 O 2 treatment inactivates LAR in mouse aortic VSMC.
A, Growth-arrested VSMC were treated with 1 mM H 2 O 2 for the indicated time and cell lysates were immunoprecipitated with anti-LAR antibody. Phosphatase activity was measured using 6,8-difluoro-4-methyl-umbelliferyl phosphate as a substrate. Data presented are mean ± S.E., (n = 3) of three separate experiments ( * , p < 0.001 compared with control). B, LAR -/-VSMC, infected with AdLAR, were growtharrested and then treated with 1 mM H 2 O 2 for the indicated times. LAR activity was measured as described above, and data presented are mean ± S.E., (n = 3) and representative of three separate experiments ( * , p < 0.001 compared with control). C, LAR activity was assayed in lysates from growth-arrested VSMC that were pretreated with 10 mM N-acetyl cysteine for 60 min and then treated with 1 mM H 2 O 2 for 20 min. Data presented are mean ± S.E., (n = 3) of three separate experiments ( * , p < 0.001 compared with control). D, The catalytic activity of recombinant LAR, in the absence of reducing agents, was assayed by monitoring the increase in absorbance resulting from the hydrolysis of substrate, p-nitrophenyl phosphate. A significant change in activity was observed for time and treatment (2-way ANOVA; p < 0.0001). 
